Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 å resolution  by Ultsch, Mark et al.
Crystal structure of the NK1 fragment of human hepatocyte
growth factor at 2.0 Å resolution
Mark Ultsch1, Nathalie A Lokker2†, Paul J Godowski2 and Abraham M de Vos1*
Background:  Hepatocyte growth factor (HGF) is a mitogen for hepatocytes and
has also been implicated as an epithelial morphogen in tumor invasion. HGF
activates its specific cellular receptor, c-met, through an aggregation mechanism
potentiated by heparan sulfate glycosaminoglycans. HGF consists of an N-terminal
(N) domain, four kringle domains (the first of which carries receptor-binding
determinants), and an inactive serine-protease-like domain. NK1, a naturally
occurring fragment of HGF, acts as an antagonist of HGF in the absence of heparin.
Results:  The N domain of NK1 consists of a central five-stranded antiparallel
β sheet flanked by an α helix and a two-stranded β ribbon. The overall N domain
structure in the context of the NK1 fragment is similar to the structure of the
isolated domain; two lysines and an arginine residue coordinate a bound sulfate
ion. The NK1 kringle domain is homologous to kringle 4 from plasminogen,
except that the lysine-binding pocket is altered by the insertion of a glycine
residue. Here, a HEPES molecule is bound in the pocket. The asymmetric unit
of the crystal contains a ‘head-to-tail’ NK1 dimer. We use this dimer to propose
a model of the NK2 fragment of HGF.
Conclusions:  A cluster of exposed lysine and arginine residues in or near the
hairpin-loop region of the N domain might form part of the NK1 heparin-
binding site. In our NK2 model, both kringle domains pack loosely against the
N domain, and a long, positively charged groove lines the interface. This
groove might be involved in glycosaminoglycan binding. The HGF receptor-
binding determinants are clustered near the binding pocket of the first kringle
domain, opposite the N domain.
Introduction
Hepatocyte growth factor (HGF; also called scatter factor),
originally purified from hepatectomized rats, has been
shown to exhibit a wide variety of cellular responses, such
as mitogenic activity for hepatocytes [1,2] and motogenic
activity for a variety of cell types including melanocytes,
renal tubular cells and keratinocytes [3–6]. In addition, it
can function as a ‘scatter factor’, an activity that promotes
the dissociation of epithelial and vascular endothelial cells
in vitro [7–9]. More recently, it was proposed that HGF is
important in tumor invasion and in embryonic development
by acting as an epithelial morphogen [10]. At the molecular
level, these events are triggered by the specific interaction
of HGF with its receptor. The HGF receptor was identified
as the product of the c-met proto-onocogene [11,12], a
190 kDa heterodimeric, membrane-spanning receptor tyro-
sine kinase, consisting of a disulfide-linked 50 kDa α chain
and a 145 kDa β chain [13]. HGF is believed to activate this
receptor by first binding to low-affinity sites at the cell
surface (glycosaminoglycans), resulting in localization and
perhaps dimerization, followed by a higher-affinity inter-
action with the less abundant c-met receptor [14]. A similar
mechanism has been proposed for receptor activation by
fibroblast growth factor [15,16].
Both rat and human HGF have been cloned [17,18]. The
mature protein corresponds to the major form purified from
human serum, which is a glycosylated, disulfide-linked
heterodimer derived by proteolytic cleavage of the human
prohormone between Arg494 and Val495. This cleavage
generates a molecule composed of a 69 kDa α chain and
a 34 kDa β chain [17,18]. It is not known whether cleav-
age is required for receptor binding or selectively for the
mitogenic, motogenic or morphogenic activities of HGF.
Sequence analysis shows that the α chain consists of an
N-terminal (N) domain homologous to that of plasminogen,
followed by four kringle domains, whereas the β chain is
highly homologous to the catalytic domain of serine pro-
teases, albeit without the characteristic catalytic triad [18]. It
has been postulated that this domain might have evolved
from the plasminogen family; it no longer has any proteolytic
activity and its biological function is still unknown [19].
A fragment of HGF consisting of the N domain plus the
first two kringle domains (‘NK2’) binds to the receptor with
only fourfold weaker affinity than the intact protein [20].
This fragment is similar to a naturally occurring variant
derived from an alternatively spliced transcript [21,22]. An
even shorter fragment, consisting of the N domain and the
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first kringle domain (‘NK1’, residues 32–210 of the intact
protein), is able to compete for receptor binding of radiola-
beled native HGF with an ~tenfold reduced affinity [23].
Recently, NK1 was also found as a natural variant encoded
by an alternative transcript [24]. Like intact HGF, NK1 has
low-affinity binding capacity for extracellular matrix proteo-
glycans and sulfoglycolipids [25]. NK1 functions as an
antagonist by competing for the receptor with native HGF
[23], but it also has weak agonist activity, which depends
strictly on the presence of heparan sulfate glycosaminogly-
cans [25,26]. Deletion and mutagenesis studies have shown
that the residues important for receptor binding of HGF are
localized primarily in the first kringle domain [20,27],
whereas heparin-binding functionality resides in the N
domain (involving the so-called hairpin-loop region) and
the second kringle domain [28].
Here we present the 2.0 Å crystal structure of the NK1 frag-
ment of HGF, containing a dimer in the crystallographic
asymmetric unit. The overall structure of the N domain in
the context of the NK1 fragment is identical to the recently
published NMR structure of the domain by itself [29]. It
has a unique fold, consisting of a central five-stranded
antiparallel β sheet flanked on one side by a short α helix
and on the other side by an antiparallel β ribbon. The
hairpin-loop region is a compact motif forming an integral
part of this domain, and disrupting its structure would cer-
tainly affect the integrity of the entire domain. Three
exposed, positively charged residues in or near this region
coordinate a sulfate ion in the crystal structure; these
residues could be involved in heparin binding. The kringle
domain shows high structural homology to the kringle 4
domain of plasminogen, but the nature of the region cor-
responding to the lysine-binding pocket of the kringle 4
domain is changed substantially due to the substitution at
several binding-pocket positions, as well as the insertion
of a glycine residue. In our crystal structure, we find a
HEPES molecule bound in this pocket. The receptor-
binding determinants, as determined by mutagenesis
studies, are located near this pocket on the surface of the
kringle domain opposite the N domain. Based on the non-
crystallographic dimer, we propose a model of NK2 in
which the second kringle domain is in contact with the
N domain. In this orientation, the interface between the
N domain and both kringle domains would contain a con-
tinuous, positively charged groove that might be involved
in glycosaminoglycan binding.
Results
Structure determination
The NK1 fragment of human HGF was crystallized in
space group P43212 with two molecules per asymmetric
unit. The structure was initially determined at 2.8 Å reso-
lution using two heavy-atom derivatives, and then refined
to R and Rfree values of 19.6% and 24.7% using all data
between 10 and 2.0 Å resolution (Table 1). The final
model includes 350 amino acid residues, two HEPES
molecules, three sulfate ions and 266 water molecules.
The model has good stereochemistry, with a root mean
square (rms) deviation from target bond lengths of
0.012 Å. Eighty-four percent of all nonglycine residues
have mainchain torsion angles in the ‘most favorable’
[30,31] regions of the Ramachandran plot, and there are
no residues other than glycine in the ‘disallowed’ regions.
The only nonglycine residue in the ‘generously allowed’
region is Glu174 of each kringle domain. This residue is
well-ordered with mainchain temperature factors between
21 and 27 Å2 (molecule 1) and 18 to 20 Å (molecule 2),
respectively; its sidechain is solvent exposed, whereas its
mainchain atoms are part of a loop stabilized by hydrogen
bonds. Three (molecule 1) or four (molecule 2) residues
at the N terminus of the NK1 construct are disordered
and not part of the final model, as are the ten antibody
‘flag’ residues preceding the N terminus; in addition, the
C-terminal residue is not visible in molecule 2. Due to
differences in crystal-packing contacts, the N domain is
significantly better ordered in molecule 1 than in mol-
ecule 2; this is reflected in the average temperature
factors (28 Å2 compared to 57 Å2) and in a smaller number
of residues with mainchain temperature factors higher
than 60 Å2 (residues 35–36 in molecule 1 compared to
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Table 1
Refinement and model statistics.
Model
Protein residues (molecule 1/molecule 2) 35–210/36–209
Number of protein residues 350
Number of HEPES molecules 2
Number of sulfate ions 3
Number of water molecules 266
Total number of nonhydrogen atoms 3077
Average B factors (Å2)
overall 37.4
molecule 1, N domain 28.4
molecule 1, kringle 33.8
molecule 1, HEPES 43.2
molecule 2, N domain 56.7
molecule 2, kringle 24.8
molecule 2, HEPES 18.7
waters 46.2
Diffraction agreement
Resolution (Å) 10.0–2.0
Completeness (%) 94.0
R value (F > 0) 0.196
Number of reflections 27 672
Free R value (F > 0) 0.247
Number of reflections 1807
Stereochemistry
Rms difference in bond distances (Å) 0.012
Rms difference in bond angles (°) 1.66
Rms ∆B of bonded atoms (Å2)
mainchain 1.9
sidechains 2.8
36–38, 50–66, 91–94 and 105–116 in molecule 2). All
residues of the kringle domains have mainchain tempera-
ture factors below 60 Å2; the kringle domain of molecule
2 (<B> = 25 Å2) is somewhat better ordered than that of
molecule 1 (<B> = 34 Å2).
Dimer arrangement and crystal environment
The two NK1 molecules in the asymmetric unit are
related by a noncrystallographic two-fold rotation axis.
The overall arrangement of the dimer is in a head-to-tail
fashion, with the N domain of one monomer packing
against the kringle domain of the other molecule
(Figure 1a). The intermolecular interface buries about
470 Å2 of solvent-accessible surface per domain. Despite
the substantial size of the area buried in the monomer–
monomer interface, there are no extensive van der Waals
contacts between the kringle domain from one monomer
and the N domain from the other, and only four inter-
molecular hydrogen bonds are found. The monomers
are approximately twofold related, and can be superim-
posed with an rms difference of 0.54 Å (142 Cα atoms).
The best superposition of the individual domains is
achieved using a rotation of 178° for the N domains
(giving an rms difference of 0.32 Å for 75 Cαs) and 180°
for the kringle domains (giving 0.25 Å for 67 Cαs).
These results suggest that the N domain–kringle linker
is somewhat flexible.
Each dimer in the NK1 crystal is surrounded by ten
neighboring molecules, with direct contacts to nine. The
crystal packing environment reveals the reason for the
difference in average temperature factors between the
two N domains. The N domain from molecule 1 forms
extensive contacts with several symmetry-related mol-
ecules, involving residues 55–63, a sulfate ion and residues
111–115. These same interactions are not found for the
second N domain, which has only two polar contacts with
a symmetry-related copy; in this molecule loop region
53–58 is poorly defined and no sulfate is found. The dif-
ference in temperature factors of the kringle domains is
not as large as for the N domains, but the kringles also
have different packing environments, and in each case
the region of the binding pocket is involved. In the
kringle domain from monomer 2 these contacts are medi-
ated by the HEPES molecule, whereas the monomer 1
kringle domain uses Arg181 to bridge to the monomer 1
N domain through a sulfate ion.
The N domain and the hairpin-loop region
In both molecules the ten-residue antibody flag as well as
the first three (molecule 1) or four (molecule 2) residues of
the N domains have no electron density, but N-terminal
sequencing of dissolved crystals showed that the crystal-
lized construct was the intact NK1 fragment with flag
attached. The N terminus is therefore disordered in the
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(a) (b)
Backbone structure of NK1. (a) The NK1 dimer found in the
asymmetric unit, with one monomer (molecule 1 in the text) in green
and the other (molecule 2) in red. Three sulfate ions and two HEPES
molecules bound to the dimer are shown in stick rendering. The termini
are labeled. (b) Stereoview Cα trace of the NK1 monomer (molecule
1), with the sulfate ions and HEPES molecule included. Every tenth
residue is labeled. The orientation in this panel is obtained from panel
(a) by a rotation of 180° about the horizontal axis. The MOLSCRIPT
[49], RASTER 3D [50] and GRASP [51] programs were used in
making the figures.
crystal, consistent with the disorder observed for these
residues in the NMR structure of the isolated domain [29].
The last 2 residues of the N domain form a short linker to
the kringle domain (Figure 1). The N domain itself has a
compact overall structure, and the structure of the domain
in the context of the NK1 fragment is identical to the
NMR structure of the isolated N domain. As has been
pointed out [29], this domain has a novel fold, containing
seven β strands (A–G), one α helix and two short pieces of
more irregular helical structure (Figure 1). The central
feature of the domain is a five-stranded, antiparallel
β sheet; this sheet is flanked on one side by the N-terminal
residues (including a helical turn at 38–41), as well as an
α helix/Ω-loop structure, and on the other side by an
antiparallel β ribbon (strands B and F). The topology of the
central sheet is AGDEC, with the helix following strand C
and connected to D by the Ω loop. The hairpin-loop region
consists of the helix and the Ω loop (residues 66–84)
together with strands D and E, which form a β hairpin
(residues 85–99). Disulfide bonds link the center of the
helix (Cys70) to strand E (Cys96) and the last turn (Cys74)
to the C-terminal end of the Ω loop (Cys84); in addition, a
hydrophobic residue from each strand (Phe87 from strand
D and Trp98 from E) packs against the disulfides. The
hairpin-loop region forms a compact motif embedded
within the N domain; the hairpin hydrogen bonds to
additional β strands at each side, and the sequence
Ala–Phe–Val–Phe (residues 86–89) on strand D anchors
the hydrophobic core within the rest of the N domain.
The kringle domain and its binding pocket
The NK1 kringle domain consists of four main loop struc-
tures. These are held together by three disulfide bonds in
a characteristic pattern [32,33]; two disulfide bonds in van
der Waals contact buried in the core of the molecule, and
the third connecting the N and C termini. The kringle
domain starts with the first cysteine residue at position 128
in the sequence. The overall fold of the kringle domain is
very similar to that of the plasminogen (PL) kringle 4
domain (K4), with a single cis-proline at residue 157 (corre-
sponding to residue 30 in PL K4) and an exposed residue
at position 174 (glutamic acid in NK1, corresponding to
Met84 in PL K4) adopting unfavorable mainchain torsion
angles (see above). The hydrophobic core of the kringle
domain is well conserved compared to other kringles
[32,33]. In contrast, the lysine- and lysine-analog-binding
pocket found in PL K4 and several other kringle domains
[32,34] is substantially different, both in character and in
structure. In PL K4 this pocket is formed by the sidechains
of Trp62 and Trp72, as well as Phe64 and Tyr74. A loop
providing two negatively charged residues (Asp55 and
Glu57) delimits the pocket on one end, and Arg71 con-
tributes positive charge at the opposite end. In the kringle
domain from NK1 an analogous pocket is present, but
three of the seven contributing residues are not conserved:
Arg181 substitutes for Asp55, Tyr198 for Trp72 and Val200
for Tyr74 (see Figure 2). In addition to these changes, a
glycine residue is inserted in the delimiting loop (NK1
residue 185; Figure 2), resulting in a substantial change in
its conformation. It is noteworthy that the mainchain con-
formation for this glycine residue (φ = 100°, ϕ = –12° for
molecule 1 and φ = 140°, ϕ = –30° for molecule 2) is unfa-
vorable for other amino acid types. Of other kringle
domains with an insertion at this position, only kringle
domain 5 of PL has a glycine and is therefore expected to
have the same loop conformation as observed for NK1. It is
more difficult to predict what the loop conformation would
be in the remaining kringle domains with the same loop
size, because there various different nonglycine residues
are inserted (histidine in kringle domain 4 of HGF, gluta-
mine in kringle domain 1 of PL, threonine and glutamine,
respectively, in the two kringle domains of prothrombin).
Taken together, the differences in the binding-pocket
residues compared to PL K4 make it appear unlikely that
lysine or lysine analogs could bind in the NK1 pocket. It is
noteworthy that in our crystal structure the pocket contains
a HEPES molecule bound in an extended conformation
(Figure 2), burying 172 Å2 of solvent-accessible surface.
The piperazine moiety is packed tightly in the hydropho-
bic part of the pocket, making van der Waals contacts to
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Figure 2
The binding pocket of the NK1 kringle. Mainchain segments are green,
sidechain carbon atoms are in light gray, oxygens are in red and
nitrogens in blue. A HEPES molecule bound in the pocket in the crystal
structure is shown with its carbon atoms in dark gray and its sulfur atom
in yellow. Hydrogen bonds are represented by dashed lines.
Val200
Tyr198
Arg197
Phe162
Gly185
Trp188
Glu195Glu159
Ser161
Structure
kringle domain residues Phe162, Trp188 and Tyr198. The
sulfonic acid group interacts with Arg197 (2.7–2.8 Å),
whereas the hydroxyl at the other end of the molecule
interacts with the glycine-insert loop via a hydrogen bond
(2.9 Å) to the mainchain carbonyl of Gly186. HEPES was
present at high (100 mM) concentrations in the crystalliza-
tion buffer; the relevance of the interactions observed is
not known, but it is possible that the pocket might have
affinity for sulfated molecules in vivo.
The interface between the N domain and the kringle
domain
The total amount of accessible surface area buried between
the N and kringle domains is about 450 Å2 per domain.
The relative orientation of the two domains differs slightly
between the two molecules in the asymmetric unit, but
the interfaces are similar. The orientation of the N domain
is such that its central sheet is positioned side-by-side
with the kringle domain (Figure 1), with Lys43, Lys44
and Ser45 on strand A involved in the interface. In addi-
tion, Met104 from loop EF (immediately following the
hairpin-loop region), Lys110 on strand F of the β ribbon,
and the linker segment (122–127) become partially buried
(Figures 1,3a). The kringle domain is oriented with its
binding pocket opposite the interface with the N domain.
The ten kringle domain residues that bury over 10 Å2 in
the interface are mainly confined to two loops: residues
135–139 and Asp171 and Glu173 (Figure 3b). The inter-
face region itself is fairly ‘wet’ in that it contains 17
ordered water molecules. There is little direct van der
Waals contact between the domains, and only a small
interdomain hydrophobic core region is found, where the
sidechain of Lys43 of the N domain is sandwiched between
the aromatic ring of Tyr 176 and the sidechains of Ile125
and Thr139 (Figure 4). Only two direct inter-domain
hydrogen bonds are present in both monomers, both
involving Lys43 of the N domain. The lysine Nζ interacts
with the Oδ1 of Asp171 (2.8 Å) and with the carbonyl
oxygen of Lys137 (3.0 Å); the sidechains of both Lys43
and Asp171 are almost totally buried in the interface. In
the context of intact HGF, mutation of the aspartic acid to
alanine decreases both receptor-binding affinity and bio-
logical activity by an order of magnitude [27], suggesting
that the ability to form this buried hydrogen bond is
important for biological activity. Given the lack of exten-
sive packing interactions, as well as the small differences
in domain–domain orientation between the two noncrys-
tallographically related molecules, it is possible that the
relative domain orientation is flexible. In that case, the
hydrogen bond between Lys43 and Asp171, and poten-
tially also that between Lys43 and Lys137, might be
important for defining the precise orientation necessary for
receptor or glycosaminoglycan binding, and hence activity.
In both molecules a sulfate ion is bound at the edge of the
interface (see Figure 1). The residues interacting with the
sulfate are mostly from the kringle domain: sulfate
oxygens are within hydrogen-binding distance (2.8–3.0 Å)
of the mainchain amides of Gly169 and Asp171, and a
nearby positive charge is provided by the sidechain of
Arg168 (3.4 Å). The nearest N domain residue is Lys110,
which provides an additional positive charge with its Nζ
atom at a distance of about 4.7 Å.
Discussion
Receptor binding
In a previous study, 42 amino acid positions within the
NK1 region were probed to investigate their importance
for receptor binding. Seven individual residues were iden-
tified, mutation of which to alanine resulted in greater
than fourfold decreases in receptor binding by HGF [27].
Only one of these residues is located in the N domain.
Asp117 is part of strand F of the β ribbon, and is sur-
rounded and almost totally buried by three lysines (Lys44,
Lys47 and Lys91) and Tyr119 (Figure 5). The aspartate
sidechain makes hydrogen bonds to the mainchain amide
of Lys47 of strand A and the Nζ of Lys91 on strand D.
Furthermore, it is spatially distant from the other residues
that are important for receptor binding. We propose that
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Figure 3
Sequence alignments, with the secondary structure elements observed
in NK1 shown at the top. (a) N domains and β strands are labeled as
described in the text. Positively charged residues discussed in the text
are in blue, residues in the intramolecular interface are underlined and
residues in the intermolecular interface are overlined. MSP, macrophage
stimulating protein (human); PL, plasminogen (human). (b) Kringle
domains. Residues colored red are the proposed receptor-binding
determinants of NK1; underlined and overlined residues as in (a).
       32      40        50        60          70        
       |       |         |         |           |         
  HGF  qrkRRNTIHEFKKSAKTTLIKIDPALKIKTKKVN--TADQCANRCTRNKG 
  MSP  VGPQRSPLNDFQVLRGTELQHLLHAVVPGPWQEDVADAEECAGRCG----
  PL   KSGQGEPLDDYVNTQGASLFS----VTKKQLGA--GSIEECAAKCEED--
   
       80        90       100       110       120
       |         |         |         |         |      
  HGF  LPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRN
  MSP  PLMDCRAFHYNVSSHGCQLLPWTQHSPHTRLRRSGRCDLFQKKDYVRT
  PL   EEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMR--DVVLFEKKVYLSE
A B C
D E F G
(b)
(a)
         130       140       150       160        170
          |         |         |         |          |     
HGF K1  CIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEH-SFLPSSYRGKDLQE
HGF K2  CMTCNGESYRGLMDHTESGKICQRWDHQTPHRH-KFLPERYPDKGFDD
PL K4   CYHGNGQSYRGTSSTTTTGKKCQSWSSMTPHRH-QKTPENYPNAGLTM
PL K5   CMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEK
  
            180       190       200       210
             |         |         |         |
HGF K1  NYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVE
HGF K2  NYCRNPDGQPR-PWCYTLDPHTRWEYCAIKTCADN-
PL K4   NYCRNPDADKG-PWCFTTDPSVRWEYCNLKKC----
PL K5   NYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQ----- Structure
the sidechain of this aspartic acid residue is important for
the structural integrity of the N domain, perhaps by neu-
tralizing the high local concentration of positive charge
and/or through its hydrogen-bonding interactions, and that
the decreased receptor-binding affinity of the alanine
mutant is an indirect, structural effect.
The other six putative receptor-binding determinants
cluster in two patches on the surface of the kringle
domain. One patch consists of Asp171 and Gln173. Although
these residues are exposed in the isolated kringle domain,
in NK1 they are almost completely buried in the interface
with the N domain (Figure 4), and we conclude that the
observed effect of the mutations is structural. Asp171
appears to have a role in stabilizing the relative domain–
domain orientation through buried hydrogen bonds to
Lys43 and Lys137 of the N domain (see above). There is
no such specific interaction for the glutamine sidechain,
but it might also be important for maintaining a specific
domain orientation. The second patch consists of Glu159,
Ser161, Glu195 and Arg197. These four residues are
located near the binding pocket of the kringle domain
(Figure 2); indeed, Arg197 interacts with the HEPES mol-
ecule that is bound in this pocket in our crystal structure.
The sidechains of the other three residues are solvent
exposed (unlike in an earlier model of the kringle domain
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Figure 4
Stereoview of the intramolecular interface
between the N domain (green) and the kringle
domain (yellow) around the salt bridge
between Lys43 and Asp171. Water molecules
are shown as red spheres, and hydrogen
bonds are represented by dashed lines.
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Figure 5
Stereoview of the environment of the
N domain Asp117.
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[27], the sidechain of Glu159 does not form a salt bridge to
Arg197). We propose that these four residues are impor-
tant binding determinants for the c-met receptor. At the
present time it is unknown whether the binding pocket
has physiological relevance, but our crystal structure sug-
gests it could have affinity for certain sulfated molecules.
Model of NK2
In our noncrystallographic dimer of NK1 the C terminus
of one kringle domain is close to the N terminus of the
other (Figure 1; see also Figure 6). The distance between
the last residue of the first monomer (residue 210) and the
N terminus of the second kringle is 9 Å. This distance
could easily be bridged by the four additional residues
(serine, glutamate, valine and glutamate) linking the
kringle domains in intact HGF. Furthermore, the intra-
molecular and intermolecular kringle–N domain interfaces
are similar in terms of total buried surface area, a relatively
large number of water molecules, as well as the absence
of extensive van der Waals contacts and hydrogen-
bonding interactions. These observations prompted us to
replace the kringle domain from the second subunit with
a model of the second kringle domain of HGF. Four of
the 10 residues burying more than 10 Å2 in the interface
are identical between kringle domains 1 and 2, and the
six differences can easily be accommodated, given the
‘looseness’ of the interface. On the basis of these findings,
we propose that the position and orientation of the second
kringle domain of HGF might resemble that of the kringle
domain of the second NK1 monomer. In our model of
NK2 (Figure 6), the second kringle domain is related to
the first kringle domain by an approximate twofold axis
and packs against the Ω loop of the N domain (residues 77
and 80–85), as well as the C-terminal N domain residues
immediately preceding the linker to the first kringle
domain (residues 123–127).
Heparin binding
HGF oligomerizes through low-affinity sites, presumably
extracellular matrix proteoglycans and sulfoglycolipids
[14,25,26]. This oligomerization is important for biological
function because there is a positive correlation between
compounds that enhance mitogenic activity and those that
promote HGF self-association. Heparin binding of HGF
has been localized to the N domain and the second kringle
domain [28], and is believed to include primary heparin-
binding determinants in the hairpin-loop region. The cal-
culated isoelectric point of the N domain is 10.3, reflecting
a large number of positively charged residues in this
domain (16 lysines and seven arginines, only partially
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Figure 6
Putative heparin-binding patches of NK1.
(a) Surface renderings of NK1 (left) and our
NK2 model (center), with a ribbon rendering
of NK2 to show the orientation (right).
Patches 1 and 2 (see text) are labeled, as are
Arg93 and Lys94. (b) Same as (a), but
rotated by approximately 90° about the
vertical axis. A large, positively charged
groove is delineated by the white contour. The
solvent-accessible surfaces are color coded
for charge (blue is positive). Sulfate ions are
shown in yellow and red, and rendered as van
der Waals spheres (left and center) or sticks
(right). In the surface renderings the bound
HEPES molecule is shown as a green patch.
N
Kringle 2
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Arg93 Lys94Arg93 Lys94
(a)
linker
C
Kringle 2
N domainKringle 1
11
(b)
Structure
counterbalanced by nine negatively charged sidechains).
Unfortunately, to date only an incomplete mutagenesis
analysis of the N domain has been performed [26]. Of the
charged residues that were tested, only a double-alanine
mutant of Arg76 and Lys78 showed a moderate effect on
heparin binding [26].
The structure shows that many of the lysines and arginines
are displayed on one face of the N domain away from the
kringle domain, resulting in a concentration of positive
charge (Figure 6a; see also Figure 5 in [29]). We distinguish
three clusters of positively charged residues: patch 1 con-
sists of the Lys60, Lys62 and Arg73 residues coordinating
the sulfate ion bound to the N domain (see above); patch 2,
nearby, contains Arg76 and Lys78 at the beginning of the
Ω loop together with Arg35 and Arg36 near the N terminus,
and a third cluster is formed by Arg93 and Lys94 at the tip
of the β hairpin (Figure 6a). On the basis of structural con-
siderations, patch 1 has been proposed to be a prime candi-
date for heparin binding, although these residues have not
been tested by mutagenesis [29]. Our observation of a
bound sulfate in this region strongly supports this hypothe-
sis. Given the weaker heparin binding of the Arg76/Lys78
double mutant [26], the second cluster might also be
involved; in this regard it should be noted that two addi-
tional nearby positively charged residues at positions 33 and
34 are disordered in our structure. Residues 93 and 94 are
farther away from these main candidates and appear less
likely to be involved.
Although the N domain is important for heparin binding,
the second kringle domain also contributes [28]. In our
model of NK2, a large, positively charged groove delin-
eates the interface between the N domain and both kringle
domains (Figure 6b). This groove starts near the sulfate ion
bound at the surface of the N domain, then loops around
the side of the N domain forming the surface of the inter-
face with the second kringle domain, and ends near the
sulfate bound by the first kringle domain. All three
domains contribute positively charged residues to the
groove: Lys109, Lys110, His114 and Lys122 (N domain);
Arg126, Lys137, Arg168, Lys170 and Arg178 (the first
kringle domain), and His225, Lys230, His270 and Arg288
(the second kringle domain). This groove is a prominent
feature of our NK2 model; based on shape and charge con-
siderations, it could potentially be a binding site for large,
negatively charged glycosaminoglycans.
In summary, the most important heparin-binding determi-
nants of the N domain are probably Lys60, Lys62 and
Arg73, with possible additional contributions from residues
near the N terminus, as well as Arg76 and Lys78. Our
NK2 model is consistent with the observation that full
heparin-binding affinity requires the presence of at least
the second kringle domain, and it is possible that the
kringle 1 domain also contributes. Confirmation of these
proposals and further details on the relative importance of
each of the candidate heparin-binding residues will depend
on more extensive mutagenesis analysis guided by the
NMR structure of the free N domain [29], as well as our
crystal structure of NK1 and model of NK2.
Biological implications
Hepatocyte growth factor (HGF) has a wide range of
biological effects, including morphogenic, mitogenic
and motogenic activities, and is implicated as a factor
involved in tumor invasion. The HGF molecule requires
endoproteolytic processing by an extracellular serine
protease to produce an active heterodimer. This pro-
cessing results in an α chain consisting of an N-termi-
nal domain (N domain), including the so-called hairpin-
loop region, followed by four kringle domains and a
β chain, that bears sequence similarity to serine pro-
teases but lacks the catalytic serine and histidine residues
critical for enzymatic activity. HGF is a member of a
growing group of growth factors that bind heparin (e.g.
fibroblast growth factor, vascular endothelial growth
factor and others). The specific receptor for HGF is
the protooncogene product c-met, a receptor tyrosine
kinase that, interestingly, is overexpressed in a large
fraction of colorectal carcinomas. Receptor activation
is believed to follow an aggregation mechanism in
which HGF first interacts with heparan sulfate proteo-
glycans, resulting in localization and concentration,
and then binds to and dimerizes the receptor.
Two shorter HGF variants have been identified that
result from alternative splicing. These variants consist of
the N domain together with the first or the first two
kringle domains and are called NK1 and NK2, respec-
tively. Both forms have near-native receptor-binding
affinity, and can activate the receptor if the proper pro-
teoglycans are present at the cell surface; in the absence
of glycosaminoglycans, NK1 is an effective HGF antag-
onist. Deletion and mutagenesis studies have shown that
the receptor-binding determinants of HGF reside in the
first kringle domain, whereas the residues important for
heparin binding are located in the N domain and the
second kringle domain. A solution structure of the iso-
lated N domain revealed it to have a new fold.
The crystal structure of the NK1 portion of HGF
shows a head-to-tail NK1 dimer in the asymmetric unit.
In the dimer, each N domain packs loosely against the
kringle domain of its own chain, as well as to the kringle
domain of the other molecule, and the interfaces are
similar in overall size and character. On the basis of this
dimer interaction, we propose a model of NK2 in which
the second kringle domain takes the place of the kringle
domain of the second molecule in our crystal structure.
The model shows a prominent, highly positively charged
groove forming the surface of the interface between the
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N domain and the two kringle domains, which could
potentially be a docking site for large, negatively
charged glycosaminoglycans. The N domain in the
context of the NK1 fragment is identical to that of the
isolated domain in solution. In the crystal structure, a
sulfate ion is bound by Lys60, Lys62 and Arg73,
strengthening the proposal that these residues are criti-
cal heparin-binding determinants.
The kringle domain of NK1 resembles the kringle 4
domain from plasminogen in overall structure, but is
remarkably different in the region corresponding to the
lysine-binding pocket. A glycine insertion changes the
structure of one end of the pocket when compared to
the kringle 4 domain, and several substitutions change
the chemical characteristics of this region, making it
unlikely that lysine or lysine analogs could bind. In our
crystal structure, a well-ordered HEPES molecule
from the crystallization buffer is present in the pocket.
It is not clear what the relevance of this finding is, but
it is noteworthy that the receptor-binding determinants
as determined by mutagenesis studies, including Glu159,
Ser161, Glu195 and Arg197, map on a patch adjacent
to this pocket. The structure also shows that additional
residues, substitution of which affected receptor binding
(Asp171 and Gln173), lie in the interface between the
N domain and the kringle domain, suggesting they
might play a structural role in defining the relative
domain–domain orientation.
Materials and methods
Purification
A construct consisting of a ten-residue antibody flag followed by the
NK1 fragment (residues 32–210 of HGF) was expressed as described
previously [23]. The purification protocol was adapted from Lokker and
Godowski [23]. A typical purification started with 500 g of thawed
Escherichia coli cell paste added to 2.5 l of a hypotonic osmotic shock
buffer (10 mM MES, 5 mM EDTA, 1 mM PMSF, pH 6.0). The cells were
homogenized using a Tekmar homogenizer, stirred for 1–2 h at 4°C, and
pelleted by centrifugation, after which the supernatant was set aside at
4°C. The cells were then resuspended in 2.5 l of 0.5 M NaCl, 20 mM
MES, 5 mM EDTA, 1 mM PMSF, pH 6.0, stirred for 1 h and pelleted,
and the resulting supernatant was added to the first batch of super-
natant. This combined pool was applied to an S-sepharose Fast Flow
(Pharmacia) column and eluted with a linear NaCl gradient from 0.25 M
to 1.5 M into 25 mM MES, pH 6.0 buffer. The fractions were assayed by
nonreducing sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) and the appropriate fractions were pooled. The pool was
diluted twofold using the above hypotonic buffer, loaded onto a 6 ml
RESOURCE S (Pharmacia) column mounted in a BIOCAD (Perceptive
BioSystems), and eluted at a speed of 30 ml/min using the same gradi-
ent as above. This procedure not only made possible a more stringent
cut of the protein peak, but also allowed quick concentration of the
protein (from 200 to 10 ml in 30 min). The protein was then adjusted to
2.5 M ammonium sulfate and loaded onto a BU/M(butyl) hydrophobic
interaction column (PerSeptive BioSystems). The NK1 fragment eluted
at 2 M ammonium sulfate in 25 mM MES, pH 6.0. The protein was
desalted, and concentrated into a buffer containing 0.15 M NaCl,
20 mM MES, 1 mM PMSF, pH 6.0 using a combination of PD10 (Phar-
macia) and Centricon 10 (Amicon), assayed by western blot, using both
anti-flag and monoclonal antibodies, and shown to be active in bioas-
says using both cellular and soluble forms of the receptor.
Crystallization
Crystals of NK1 were initially grown using the hanging-drop technique
and sparse-matrix method [35]. Small crystalline rods were observed
growing from a drop that contained 30% (50% stock w/w) PEG 3400,
0.1 M HEPES pH 7.5 and 50 mM Na/K phosphate. These rods dif-
fracted poorly to 3.5 Å, allowing the space group to be determined as
P21 with a = 59.0Å, b = 86.0Å, c = 90.0Å, β = 96.0°. The optimal condi-
tion was found to be vapor diffusion in sitting drops containing 50µl of
protein solution at 3mg/ml [ε0.1% (280 nm) = 1.16] and 25 µl of reservoir
[20% (50% stock w/w) PEG 3400 (Aldrich), 0.1 M HEPES, 0.3 M
ammonium sulfate, pH 7.5]. Seed crystals were introduced after
five days, and multi-faceted, triangularly shaped crystals with a size of
0.3 × 0.3 × 0.3 mm grew in approximately three weeks. The space group
determination was carried out using an Enraf–Nonius precession
camera mounted on a Rigaku RU200 rotating-anode generator oper-
ated at 5.0 kW. The space group was found to be P41(3)212 with unit
cell axes of a = 88.32 Å, c = 117.284 Å. Two molecules per asymmetric
unit correspond to a Matthew’s parameter [36] of 2.8 Å3/Da.
Data collection
All data collection was done at room temperature. One native crystal
was used to collect an initial native dataset to 2.65 Å [Rmerge(I) = 0.063,
completeness 97%] on an Enraf Nonius FAST area detector and a
Rigaku RU200 X-ray generator operated at 5.0 kW, and using
MADNES [37] and PROCOR [38] processing software. Using the
same equipment and software, two 2.8 Å heavy atom derivative
datasets were collected, each from a single crystal soaked in either
2 mM K2PtI6 [4 days; Rmerge(I) = 0.077, completeness 98%] or 2 mM
U(OOCCH3)2O2.2H2O [11 days; Rmerge(I) = 0.070, completeness
97%]. A second native crystal was used to collect a dataset to 2.4 Å
on a MAR imaging plate and a Rigaku RU200 X-ray generator oper-
ated at 5.0 kW, and processed using XDS [38] (Rmerge = 0.055,
average redundancy 4.4, completeness 95%). The FAST and MAR
datasets were used to solve the structure and do preliminary refine-
ment. A third native dataset was collected to 2.0 Å from seven crys-
tals at the Cornell High Energy Synchrotron Source (CHESS),
beamline A1, using Fuji imaging plates and covering a rotation range
of 99° in 1.0° increments. The high redundancy of this dataset made
it possible to use only fully recorded reflections during the process-
ing with DENZO [39], resulting in 89% complete data coverage
[Rmerge(I) = 0.056 with an average redundancy of 5.2]. However,
because of saturation of the imaging plates, this dataset was only
64% complete between 20 and 4.0 Å resolution. A 94% complete
dataset (10 to 2.0 Å) was produced by combining the CHESS data
with the in-house MAR data [Rmerge(I) = 0.066]; this combined
dataset was subsequently used in refinement.
Structure determination
The structure was solved by multiple isomorphous replacement and
anomalous scattering using the datasets collected on the FAST
detector. Scaling the platinum iodide and uranyl acetate derivative
datasets to the native data produced R values (on F) of 0.21 and
0.15, respectively. Heavy atom positions were determined using the
program HASSP [40], and the anomalous differences were used to
assign the enantiomorph as P43212. Phase refinement was carried
out using the PROTEIN package [41], resulting in a phasing power
for the platinum iodide and uranyl acetate derivatives of 1.91 and
1.17, respectively, and a final figure of merit of 0.53 (15 to 2.8 Å res-
olution). These phases were solvent flattened according to Wang
[42], which increased the figure of merit to 0.63. The solvent-flat-
tened map showed clear electron density corresponding to the
central β sheet of the N domain, and allowed building of most of the
N domain as well as the entire kringle using the program FRODO
[43]. Modeling of the kringle domain was facilitated by using the plas-
minogen kringle 4 structure [33] as a template.
Refinement
Refinement was done using the program X-PLOR [44] and the stereo-
chemical restraints from Engh and Huber [45], after sequestering 6% of
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the reflections to monitor progress by means of the free R value [46]. In
the first three rounds, the model was extended and manually adjusted
on the basis of σA-weighted, phase-combined electron-density maps
[47]. At this stage, the 2.4 Å MAR dataset became available. Noncrys-
tallographic symmetry (NCS) restraints were placed on those portions
of the molecules that were most alike (about 90% of the structure). Bulk
solvent and anisotropy corrections were not applied. Simulated anneal-
ing [40,48] was used intermittently by typically heating the model to
2000K; this was usually followed by 100 cycles of positional refinement.
At an early stage, density from Fo–Fc difference electron-density maps
suggested that each kringle binding pocket was occupied, and when
the R value had dropped to 27.5%, a HEPES molecule was built into
this density. From this point on, the 2.0 Å dataset was used in rounds of
conjugate gradient refinement (coordinates and individual isotropic B
factors) and map fitting. Water molecules were placed in difference
peaks appearing at stereochemically reasonable positions if there was
greater than 3σ Fo–Fc density, as well as greater than 1σ 2Fo–Fc
density; three 6σ peaks were modeled as sulfates. In the last round of
refinement the NCS restraints were removed. The final free R value for
the 1807 sequestered reflections between 10 and 2.0 Å is 24.7%. The
final model consists of 350 protein residues, two HEPES molecules,
three sulfates, and 266 water molecules (Table 1).
Accession numbers
The coordinates have been deposited in the Brookhaven Protein Data
Bank for immediate release; the accession code is 1 bht.
Acknowledgements
We thank the staff at CHESS for help with beamline A1. We also thank the
following colleagues formerly or presently at Genentech, Inc.: Norm Lin for
fermentation runs, Will Somers, Yves Muller and Mike Randal for help with
data collection and processing, Axel Scheidig for help with modeling, Chris-
tian Wiesmann for extensive help with the figures and useful comments on
the manuscript, and Tony Kossiakoff for advice and discussions. 
References
1. Michalopoulos, G., Houck, K.A., Dolan, M.L. & Luetteke, N.C.
(1984). Control of hepatocyte replication by two serum factors.
Cancer Res. 44, 4414-4419.
2. Nakamura, T., Nawa, K. & Ichihara, A. (1984). Partial purification
and characterization of hepatocyte growth factor from serum of
hepatectomized rats. Biochem. Biophys. Res. Commun. 122,
1450-1459.
3. Igawa, T., et al., & Nakamura, T. (1991). Hepatocyte growth factor is a
potent mitogen for cultured rabbit renal tubular epithelial cells.
Biochem. Biophys. Res. Commun. 174, 831-838.
4. Kan, M., et al., & Stevens, J.I. (1991). Hepatocyte growth
factor/hepatopoietin A stimulates the growth of rat kidney proximal
tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human
melanoma cells, mouse keratinocytes and stimulates anchorage-
independent growth of SV-40 transformed RPTE. Biochem. Biophys.
Res. Commun. 174, 331-337.
5. Matsumoto, K., Tajima, H. & Nakamura, T. (1991). Hepatocyte growth
factor is a potent stimulator of human melanocyte DNA synthesis and
growth. Biochem. Biophys. Res. Commun. 176, 45-51.
6. Rubin, J.S., et al., & Aaronson, S.A. (1991). A broad-spectrum human
lung fibroblast-derived mitogen is a variant of hepatocyte growth
factor. Proc. Natl Acad. Sci. USA 88, 415-419.
7. Stoker, M., Gherardi, E., Perryman, M. & Gray, J. (1987). Scatter factor
is a fibroblast-derived modulator of epithelial cell mobility. Nature 327,
239-242.
8. Weidner, M.K., Behrens, J., Vandekerckhove, J. & Birchmeier, W.
(1990). Scatter factor: molecular characteristics and effect on the
invasiveness of epithelial cells. J. Cell Biol. 111, 2097-2108.
9. Naldini, L., et al., & Comoglio, P.M. (1991). Scatter factor and
hepatocyte growth factor are indistinguishable ligands for the MET
receptor. EMBO J. 10, 2867-2878.
10. Montesano, R., Matsumoto, K. & Nakamura, T. (1991). Identification of
a fibroblast-derived epithelial morphogen as hepatocyte growth factor.
Cell 67, 901-908.
11. Naldini, L., et al., & Comoglio, P.M. (1991). Hepatocyte growth factor
(HGF) stimulates the tyrosine kinase activity of the receptor encoded
by the proto-oncogene c-MET. Oncogene 6, 501-504.
12. Bottaro, D.P., et al., & Aaronson, S.A. (1991). Identification of the
hepatocyte growth factor receptor as the c-met proto-oncogene
product. Science 251, 802-804.
13. Park, M., Dean, M., Kaul, K., Braun, M.J., Gonda, M.A. & Vande
Woude, G. (1987). Sequence of MET protooncogene cDNA has
features characteristic of the tyrosine kinase family of growth factors.
Proc. Natl Acad. Sci. USA 84, 6379-6383.
14. Zioncheck, T.F., et al., & Stack, R.J. (1995). Sulfated oligosaccharides
promote hepatocyte growth factor association and govern its
mitogenic activity. J. Biol. Chem. 270, 16871-16878.
15. Ornitz, D.M., Herr, A.B., Nilsson, M., Westman, J., Svahn, C.-M. &
Waksman, G. (1995). FGF binding and FGF receptor activation by
synthetic heparan-derived di- and trisaccharides. Science 268, 432-436.
16. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J. & Rees, D.C.
(1996). Heparin structure and interactions with basic fibroblast
growth factor. Science 271, 1116-1120.
17. Miyazawa, K., et al., & Kitamura, N. (1989). Molecular cloning and
sequence analysis of cDNA for human hepatocyte growth factor.
Biochem. Biophys. Res. Commun. 163, 967-973.
18. Nakamura, T., et al., & Shimuzi, S. (1989). Molecular cloning and
expression of human hepatocyte growth factor. Nature 342, 440-443.
19. Donate, L.E., Gherardi, E., Srinivasan, N., Sowdhamini, R., Aparicio, S.
& Blundell, T.L. (1994). Molecular evolution and domain structure of
plasminogen-related growth factors (HGF/SF and HGF1/MSP).
Protein Sci. 3, 2378-2394.
20. Lokker, N.A., et al., & Godowski, P.J. (1992). Structure-function
analysis of hepatocyte growth factor: identification of variants that lack
mitogenic activity yet retain high affinity receptor binding. EMBO J. 11,
2503-2510.
21. Miyazawa, K., Kitamura, A., Naka, D. & Kitamura, N. (1991). An
alternatively processed mRNA generated from human hepatocyte
growth factor gene. Eur. J. Biochem. 197, 15-22.
22. Chan, A.M., Rubin, J.S., Bottaro, D.P., Hirschfield, D.W., Chedid, M. &
Aaronson, S.A. (1991). Identification of a competitive HGF antagonist
encoded by an alternative transcript. Science 254, 1382-1385.
23. Lokker, N.A & Godowski, P.J. (1993). Generation and characterization
of a competitive antagonist of human hepatocyte growth factor,
HGF/NK1. J. Biol. Chem. 268, 17145-17150.
24. Cioce, V., et al., & Rubin, J.S. (1996). Hepatocyte growth factor
(HGF)/NK1 is a naturally occurring HGF/scatter factor variant with
partial agonist/antagonist activity. J. Biol. Chem. 271, 13110-13115.
25. Schwall, R.H., et al., & Zioncheck, T.F. (1996). Heparin induces
dimerization and confers proliferative activity onto the hepatocyte
growth factor antagonists NK1 and NK2. J. Cell Biol. 133, 709-718.
26. Sakata, H., et al., & Rubin, J.S. (1997). Heparin binding and
oligomerization of hepatocyte growth factor/scatter factor isoforms.
Heparan sulfate glycosaminoglycan requirement for Met binding and
signaling. J. Biol. Chem. 272, 9457-9463.
27. Lokker, N.A., Presta, L.G. & Godowski, P.J. (1994). Mutational analysis
and molecular modeling of the N-terminal kringle-containing domain of
hepatocyte growth factor identifies amino acid sidechains important
for interaction with the c-Met receptor. Protein Eng. 7, 895-903.
28. Mizuno, K., et al., & Nakamura, T. (1994). Hairpin loop and second
kringle domain are essential sites for heparin binding and biological
activity of hepatocyte growth factor. J. Biol. Chem. 269, 1131-1136.
29. Zhou, H., et al., & Byrd, R.A. (1998). The solution structure of the 
N-terminal domain of the hepatocyte growth factor reveals a potential
heparin-binding site. Structure 6, 109-116.
30. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M.
(1993). Procheck: a program to check the stereochemical quality of
protein structures. J. Appl. Crystallogr. 26, 283-291.
31. Morris, A.L., MacArthur, M.W., Hutchinson, E.G. & Thornton, J.M.
(1992). Stereochemical quality of protein structure coordinates.
Proteins 12, 345-364.
32. De Vos, A.M., et al., & Kossiakoff, A.A. (1992). Crystal structure of the
kringle-2 domain of tissue plasminogen activator at 2.4 Å resolution.
Biochemistry 31, 270-279.
33. Mulichak, A.M., Tulinsky, A. & Ravichandran, K.G. (1991). Crystal and
molecular structure of the human plasminogen kringle 4 refined at
1.9 Å resolution. Biochemistry 30, 10576-10588.
34. Wu, T.-P., Padmanabhan, K., Tulinsky, A. & Mulichak, A.M. (1991). The
refined structure of the ε-aminocaproic acid complex of human
plasminogen kringle 4. Biochemistry 30, 10589-10594.
35. Jancarik, J. & Kim, S.-H. (1991). Sparse matrix sampling: a screening
method for crystallization of proteins. J. Appl. Crystallogr. 24, 409-411.
36. Matthews, B.W. (1968). Solvent content of protein crystals. J. Mol.
Biol. 33, 491-497.
1392 Structure 1998, Vol 6 No 11
37. Messerschmidt, A. & Pflugrath, J.W. (1987). Crystal orientation and X-ray
pattern prediction routines for area-detector diffractometer systems in
macromolecular crystallography. J. Appl. Crystallogr. 20, 306-315.
38. Kabsch, W. (1988). Evaluation of single-crystal X-ray diffraction data
from a position sensitive detector. J. Appl. Crystallogr. 21, 916-924.
39. Otwinowski, Z. (1993). Oscillation data reduction program. In
Proceedings of the CCP4 Study Weekend: Data Collection and
Processing. (Sawyer, L., Isaacs, N. & Bailey, S., eds.), pp. 56-62,
SERC Daresbury Laboratory, UK.
40. Terwilliger, T., Kim, S.-H. & Eisenberg, D. (1987). Generalized method
of determining heavy-atom positions using the difference Patterson
function. Acta Crystallogr. A43, 1-6.
41. Steigemann, W. (1989). PROTEIN, a program for the crystal structure
analysis of proteins. Max-Planck-Institut für Biochemie, Markinsreid bei
München, Germany.
42. Wang, B.C. (1985). Resolution of phase ambiguity in macromolecular
crystallography. Methods Enzymol. 115, 90-112.
43. Jones, A.T. (1985). Interactive computer graphics: FRODO. Methods
Enzymol. 115, 157-171.
44. Brünger, A.T., Kuriyan, J. & Karplus, M. (1987). Refinement by
simulated annealing. Science 235, 458-460.
45. Engh, R.A. & Huber, R. (1991). Accurate bond and angle parameters for
X-ray protein structure refinement. Acta Crystallogr. A 47, 392-400.
46. Brünger, A.T. (1992). Free R value: a novel statistical quantity for
assessing the accuracy of crystal structures. Nature 355, 472-475.
47. Read, R.J. (1986). Improved fourier coefficients for maps using phases
from partial structures with error. Acta Crystallogr. A 42, 140-149.
48. Brünger, A.T., Krukowski, A. & Erickson, J.W. (1990). Slow cooling
protocols for crystallographic refinement by simulated annealing. Acta
Crystallogr. A 46, 585-593.
49. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed
and schematic plots of protein structures. J. Appl. Crystallogr. 24,
946-950.
50. Merritt, E.A. & Murphy, M.E.P. (1994). RASTER 3D version 2.0, a
program for photorealistic molecular graphics. Acta Crystallogr. D
50, 869-873.
51. Nicholls, A., Bharadwaj, R. & Honig, B. (1993). GRASP: graphical
representation and analysis of surface properties. Biophys. J. 64,
166-170.
Research Article  Crystal structure of the NK1 fragment of HGF Ultsch et al.    1393
